Oxford Asset Management’s Avanos Medical AVNS Stock Holding History

Oxford Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Buy	+42,627	New	+$998K	0.52%	38
2025 Q3	–	Sell	-11,922	Closed	-$146K	–	461
2025 Q2	$146K	Buy	11,922 +684	+6%	+$8.6K	0.05%	456
2025 Q1	$161K	Buy	+11,238	New	+$175K	0.07%	382
2018 Q3	–	Sell	-28,718	Closed	-$1.64M	–	1686
2018 Q2	$1.64M	Buy	+28,718	New	+$1.52M	0.03%	779
2017 Q4	–	Sell	-69,175	Closed	-$3.15M	–	1612
2017 Q3	$3.15M	Buy	69,175 +13,761	+25%	+$587K	0.06%	382
2017 Q2	$2.18M	Sell	55,414 -10,573	-16%	-$400K	0.04%	569
2017 Q1	$2.51M	Sell	65,987 -10,203	-13%	-$398K	0.06%	357
2016 Q4	$2.82M	Sell	76,190 -19,221	-20%	-$687K	0.1%	211
2016 Q3	$3.31M	Buy	+95,411	New	+$3.34M	0.1%	261

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Oxford Asset Management's AVNS Position: Q2 2026 in Review

Oxford Asset Management opened a new position in Avanos Medical (AVNS) in Q2 2026: 42,627 shares worth $1.06M. The stake represents 0.52% of the portfolio and ranks #38 among its holdings. This is a return to the name: Oxford Asset Management previously reported a position in AVNS as recently as Q2 2025.

Oxford Asset Management first reported a position in AVNS in Q3 2016 and has held it in 9 quarters since. The position peaked at $3.31M in Q3 2016. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Oxford Asset Management held 42,627 shares of Avanos Medical worth $1.06M as of Q2 2026.
Avanos Medical was a new Oxford Asset Management position in Q2 2026.
Avanos Medical made up 0.52% of Oxford Asset Management's portfolio in Q2 2026, its #38 holding.
Oxford Asset Management first reported a position in Avanos Medical in Q3 2016 and has held it in 9 quarters since.
Oxford Asset Management's Avanos Medical position peaked at $3.31M in Q3 2016.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.